Ayurveda medicine approved for clinical trials on COVID-19 patients

In vitro experiments done at the Rajiv Gandhi Center for Biotechnology has proven that there are no side effects in the human cell. Subsequently, the approval was received from the Institutional Ethics Committees (IEC), basis which the Central Government’s CTRI (Clinical Trial Registry of India, which comes under the ICMR, has provided approval and granted permission to conduct Randomised single-blinded placebo-controlled prospective multicenter interventional clinical trial to various medical colleges across the country.”

This comes at a time when search for therapeutic options against the Novel Coronavirus (SARS-CoV2) is going on at a frenetic pace the world over.